31.08.2018 • NewsElaine BurridgeMerckProcter & Gamble

EU Clears Merck’s Consumer Health Sale to P&G

EU Clears Merck’s Consumer Health Sale to P&G
EU Clears Merck’s Consumer Health Sale to P&G

The European Commission has approved the sale by Merck KGaA of its global consumer health business to Procter & Gamble (P&G). The regulator said it had no competition concerns, noting that the activities of both companies are generally complementary and give rise to a limited number of horizontal overlaps, with sufficient competition remaining post-merger.

In April of this year, the German company signed an agreement to sell the division to the US consumer products giant for around €3.4 billion in cash. The acquisition adds Merck’s vitamin and food supplements, such as Seven Seas, to P&G’s portfolio that features a range of over-the-counter medicines including Vicks cough and cold products, along with well-known brands such as Pampers diapers and Gillette razors.

The deal, which is said to be one of the biggest that P&G has done in recent years, also boosts the US group’s presence in Latin America and Asia.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.